Global 3D Cell Culture Market to Observe Widespread Growth with Growing Occurrence of Oncological Diseases

Over the past couple of years, the life sciences sector has seen a tremendous shift. Cell culture involves the use of growing cells in a controlled environment to understand how cells respond to their surroundings. Currently, a number of cell cultures are available, and based on their features and intended uses, some may be best suited than others. Amongst them, 3D cell culture has become more popular due to its unique and practical properties as compared to the traditional cell culture method.

Cells developed in three-dimensional cell culture models are physiologically relevant. They have made various advancements in several studies of biological mechanisms including proliferation, cell morphology, cell number monitoring, differentiation, viability, and others. Thus, 3D cell cultures are useful for analysing and studying the etiology of disorders, which enables their use in scientific research. The benefits that 3D cell culture offers over traditional 2D cell cultures in terms of cell-to-matrix and cell-to-cell interactions are mainly responsible for this growth rate. Due to advancements in technology that are improving 3D cell culture, the global 3D cell culture market is growing rapidly.

Newest Insights in the 3D Cell Culture Market

The number of patients suffering from oncological diseases like lung cancer, skin cancer, and others has increased greatly in the last few years. These patients have benefited from new advancements in the field of 3D cell culture. As per a report by Research Dive, the global 3D cell culture market is expected to surpass a revenue of $5,656.7 million in the 2022-2031 timeframe. The North America 3D cell culture market is expected to perceive foremost and dominant growth in the years to come. This is because the region has significant financial support from private and government organizations for the development of innovative 3D cell culture models and the presence of many universities and research organizations studying various stem cell-based methods in the region.

How are Market Players Responding to the Rising Demand for 3D Cell Culture?

Market players are greatly investing in pioneering research and inventions to develop innovative and advanced 3D cell culture techniques. Some of the foremost players in the 3D cell culture market are Thermo Fisher Scientific, Corning Incorporated, 3D Biotek, TissUse GmbH, QGel SA, Hµrel Corporation, SynVivo, Advanced BioMatrix, Lonza, Greiner Bio-One International, and others. These players are focused on planning and devising tactics such as mergers and acquisitions, collaborations, novel advances, and partnerships to reach a notable position in the global market.

For instance,

• In August 2021, Amerigo Scientific, a distribution company that specialises in supplying crucial items and services to the biomedical and life science research sectors, expanded its cell culture portfolio with the introduction of 3D Cell Culture for scientific usage. This novel 3D cell culture system may be utilised in research areas like the evaluation of nanomaterials, medicine, drug discovery, and basic life science.
   
• In January 2021, Jellagen Limited, a biotechnology company that manufactures next-generation collagen products sourced from Jellyfish for application in 2D and 3D cell culture and medical devices, launched a 3D hydrogel. JellaGel offers customers a natural, non-mammalian, consistent, biochemically simple, and simple-to-use hydrogel that can revolutionise their research.
   
• In December 2020, eNuvio, a designer and producer of novel cutting-edge tools for the drug discovery, life science research, and safety assessment markets, announced the launch of the EB-Plate, the first ever completely reusable 3D cell culture microplate in the market. With this launch, eNuvio aims to obtain a leading position in the 3D cell culture market.

COVID-19 Impact on the Global 3D Cell Culture Market

The unpredicted rise of the coronavirus pandemic in 2020 has positively impacted the global 3D cell culture market. The COVID-19 pandemic has put a burden on the world's healthcare systems. After the WHO declared the COVID-19 outbreak a pandemic, well-known biopharmaceutical and pharmaceutical companies increased their production and R&D efforts to create and sell vaccines, test kits, and therapies against the SARS-CoV-2 virus. Viral vaccines made from cell cultures are being utilized to immunize people against diseases all over the world. The SARS-CoV-2 virus is now grown in research using mammalian cell lines. In order to produce treatments with the necessary level of pharmacological activity under controlled environmental conditions, culture mediums are a source of nutrients and component cells. Researchers can analyse biological activity using bioreactors, scaffolds, vessels, and other 3D cell culture techniques to mimic in vivo conditions. All these factors are projected to drive the growth of the 3D cell culture market in the forthcoming years.